Forbion European Acquisition Corp. (NASDAQ:FRBN – Get Rating) was the target of a significant increase in short interest during the month of August. As of August 31st, there was short interest totalling 800 shares, an increase of 100.0% from the August 15th total of 400 shares. Approximately 0.0% of the company's stock are sold short. Based on an average trading volume of 22,400 shares, the days-to-cover ratio is currently 0.0 days.
Forbion European Acquisition Trading Up 0.1 %
FRBN opened at $10.09 on Friday. The business's 50-day simple moving average is $10.04 and its 200 day simple moving average is $9.99. Forbion European Acquisition has a 52-week low of $9.86 and a 52-week high of $10.09.
Get Forbion European Acquisition alerts:Institutional Inflows and Outflows
Institutional investors have recently made changes to their positions in the stock. Glazer Capital LLC bought a new position in shares of Forbion European Acquisition in the first quarter valued at $156,000. OMERS ADMINISTRATION Corp acquired a new position in shares of Forbion European Acquisition during the 1st quarter worth about $199,000. UBS Group AG bought a new stake in shares of Forbion European Acquisition in the 1st quarter valued at about $249,000. Prelude Capital Management LLC bought a new stake in shares of Forbion European Acquisition in the 1st quarter valued at about $508,000. Finally, JPMorgan Chase & Co. acquired a new stake in Forbion European Acquisition in the 1st quarter valued at about $654,000. Institutional investors and hedge funds own 52.63% of the company's stock.
About Forbion European Acquisition
(Get Rating)Forbion European Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to identify opportunities in the life sciences industry in Europe.
Read More
- Get a free copy of the StockNews.com research report on Forbion European Acquisition (FRBN)
- 3 Banks Worth Considering For Q4
- Stock Market: 3 Islands Of Strength In A Sea Of Red
- Is There a Cure for What is Ailing Teladoc Stock?
- MarketBeat: Week in Review 9/12 – 9/16
- No One Told These 3 Stocks It's a Down Week
Receive News & Ratings for Forbion European Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Forbion European Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.